CLOV — Clover Health Investments Income Statement
0.000.00%
Last trade - 00:00- $331.90m
- $33.58m
- $2.03bn
- 30
- 62
- 54
- 46
Annual income statement for Clover Health Investments, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 1,472 | 3,477 | 2,034 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 0.018 | 6.86 | 2,109 | 3,824 | 2,242 |
| Operating Profit | -0.018 | -6.86 | -637 | -348 | -209 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.018 | -6.74 | -588 | -339 | -213 |
| Net Income After Taxes | -0.018 | -6.74 | -588 | -339 | -213 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.018 | -6.74 | -588 | -339 | -213 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.018 | -6.74 | -588 | -339 | -213 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0 | -0.065 | -1.42 | -0.76 | -0.389 |
| Dividends per Share |